Literature DB >> 16794288

Intravenous artesunate recommended for patients with severe malaria: position statement from TropNetEurop.

Tomas Jelinek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16794288     DOI： 10.2807/esw.10.47.02841-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


× No keyword cloud information.
  5 in total

1.  Treatment of malaria in Austria: hazardous for patients or physicians?

Authors:  Sabine Bélard; Florian Kurth; Stefan Winkler; Wolfgang Graninger; Michael Ramharter
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Combined intravenous treatment with artesunate and quinine for severe malaria in Italy.

Authors:  Alessandro Bartoloni; Lina Tomasoni; Filippo Bartalesi; Luisa Galli; Spartaco Sani; Sara Veloci; Lorenzo Zammarchi; Alessandro Pini; Francesco Castelli
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

3.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

4.  Intravenous artesunate for severe malaria in travelers, Europe.

Authors:  Thomas Zoller; Thomas Junghanss; Annette Kapaun; Ida Gjorup; Joachim Richter; Mats Hugo-Persson; Kristine Mørch; Behruz Foroutan; Norbert Suttorp; Salih Yürek; Holger Flick
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

5.  Severe malaria and artesunate treatment, Norway.

Authors:  Kristine Mørch; Øystein Strand; Oona Dunlop; Ase Berg; Nina Langeland; Rafael A M Leiva; Jørn-Age Longva; Håkon Sjursen; Steinar Skrede; Jon Sundal; Mogens Jensenius
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.